169 related articles for article (PubMed ID: 1691260)
1. A comparative study of straight chain and branched chain fatty acid oxidation in skin fibroblasts from patients with peroxisomal disorders.
Singh H; Usher S; Johnson D; Poulos A
J Lipid Res; 1990 Feb; 31(2):217-25. PubMed ID: 1691260
[TBL] [Abstract][Full Text] [Related]
2. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
Poulos A; Singh H; Paton B; Sharp P; Derwas N
Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
[TBL] [Abstract][Full Text] [Related]
3. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of branched chain fatty acids in peroxisomal disorders.
Singh H; Usher S; Johnson D; Poulos A
J Inherit Metab Dis; 1990; 13(3):387-9. PubMed ID: 1700192
[No Abstract] [Full Text] [Related]
5. Formation of a novel arachidonic acid metabolite in peroxisomes.
Gordon JA; Heller SK; Rhead WJ; Watkins PA; Spector AA
Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):77-81. PubMed ID: 7540307
[TBL] [Abstract][Full Text] [Related]
6. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ
J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
[TBL] [Abstract][Full Text] [Related]
7. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
[TBL] [Abstract][Full Text] [Related]
8. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
[TBL] [Abstract][Full Text] [Related]
9. Peroxisomal beta-oxidation of branched chain fatty acids in human skin fibroblasts.
Singh H; Brogan M; Johnson D; Poulos A
J Lipid Res; 1992 Nov; 33(11):1597-605. PubMed ID: 1464743
[TBL] [Abstract][Full Text] [Related]
10. Peroxisomal beta-oxidation of branched chain fatty acids in rat liver. Evidence that carnitine palmitoyltransferase I prevents transport of branched chain fatty acids into mitochondria.
Singh H; Beckman K; Poulos A
J Biol Chem; 1994 Apr; 269(13):9514-20. PubMed ID: 8144536
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
[TBL] [Abstract][Full Text] [Related]
12. Very long-chain fatty acids in peroxisomal disease.
Poulos A; Beckman K; Johnson DW; Paton BC; Robinson BS; Sharp P; Usher S; Singh H
Adv Exp Med Biol; 1992; 318():331-40. PubMed ID: 1378993
[TBL] [Abstract][Full Text] [Related]
13. Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz.
Singh I; Pahan K; Dhaunsi GS; Lazo O; Ozand P
J Biol Chem; 1993 May; 268(14):9972-9. PubMed ID: 8486724
[TBL] [Abstract][Full Text] [Related]
14. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
15. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical and biochemical studies of fatty acid oxidation in fibroblasts of Zellweger and X-linked adrenoleukodystrophy patients.
Reubsaet FA; Veerkamp JH; Brückwilder ML; Trijbels JM; Hashimoto T; Monnens LA
Biochim Biophys Acta; 1991 Jun; 1083(3):305-9. PubMed ID: 2049396
[TBL] [Abstract][Full Text] [Related]
17. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
19. Localization of nervonic acid beta-oxidation in human and rodent peroxisomes: impaired oxidation in Zellweger syndrome and X-linked adrenoleukodystrophy.
Sandhir R; Khan M; Chahal A; Singh I
J Lipid Res; 1998 Nov; 39(11):2161-71. PubMed ID: 9799802
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease.
Wanders RJ; Heymans HS; Schutgens RB; Poll-Thé BT; Saudubray JM; Tager JM; Schrakamp G; van den Bosch H
J Neurol Sci; 1988 Apr; 84(2-3):147-55. PubMed ID: 2454298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]